Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharmagora Plus 2025Pharmagora Plus 2025
Not Confirmed
Not Confirmed
08-09 March, 2025
Organic Process R&DOrganic Process R&D
Not Confirmed
Not Confirmed
10-12 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharmagora Plus 2025Pharmagora Plus 2025
Industry Trade Show
Not Confirmed
08-09 March, 2025
Organic Process R&DOrganic Process R&D
Industry Trade Show
Not Confirmed
10-12 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
18 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/18/3027747/37568/en/Petosemtamab-granted-Breakthrough-Therapy-designation-by-the-U-S-FDA-for-1L-PD-L1-positive-head-and-neck-squamous-cell-carcinoma.html
13 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/13/3025842/37568/en/Merus-to-Present-at-Citi-s-2025-Virtual-Oncology-Leadership-Summit.html
05 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/05/3021636/37568/en/New-England-Journal-of-Medicine-Publishes-Efficacy-of-Zenocutuzumab-in-NRG1-Fusion-Positive-Cancer.html
12 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/13/3008083/37568/en/Merus-and-Biohaven-Announce-Collaboration-to-Co-Develop-Three-Novel-Bispecific-ADC-Programs.html
16 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/16/2997871/37568/en/Merus-announces-First-Patient-Dosed-in-Phase-2-Trial-of-Petosemtamab-in-3L-mCRC.html
05 Dec 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-merus-therapy-treat-lung-pancreatic-cancers-2024-12-04/
ABOUT THIS PAGE